Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study
Hongyan Zhang,1 Huafang Li,2 Yanning Liu,3 Cathy Wu,3 Qingqi Wu,3 Isaac Nuamah,4 Jianguo Shi,5 Shiping Xie,6 Gang Wang,7 Srihari Gopal4 1Peking University 6th Hospital, Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Be...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/d01f90e9d6d646469a4adf23b49b1be6 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!